The results obtained from three prospective epidemiological studies have indicated a significant positive association between premenopausal plasma AMH levels and the risk of breast cancer (Dorgan et al. 2009, Nichols et al. 2015, Eliassen et al. 2016). This evidence concerns the gene AMH and breast cancer.